AirSculpt Technologies, Inc.
AirSculpt Technologies, Inc. AIRS Peers
See (AIRS) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AIRS | $3.57 | +0.56% | 209.84M | -12.31 | -$0.29 | N/A |
| HCA | $387.69 | +0.57% | 93.27B | 17.21 | $22.53 | +0.70% |
| FMS | $28.77 | +1.30% | 16.88B | 24.38 | $1.18 | +2.46% |
| THC | $165.41 | +0.84% | 15.36B | 10.61 | $15.59 | N/A |
| SOLV | $74.10 | +1.58% | 12.82B | 34.15 | $2.17 | N/A |
| UHS | $198.03 | +1.10% | 12.76B | 11.12 | $17.81 | +0.41% |
| EHC | $120.82 | +0.88% | 12.18B | 24.91 | $4.85 | +0.55% |
| DVA | $145.37 | +1.23% | 10.98B | 14.41 | $10.09 | N/A |
| OSH | $39.00 | +0.08% | 9.52B | -17.65 | -$2.21 | N/A |
| ENSG | $149.75 | +1.84% | 8.61B | 28.25 | $5.30 | +0.16% |
Stock Comparison
AIRS vs HCA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, HCA has a market cap of 93.27B. Regarding current trading prices, AIRS is priced at $3.57, while HCA trades at $387.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas HCA's P/E ratio is 17.21. In terms of profitability, AIRS's ROE is -0.21%, compared to HCA's ROE of -2.36%. Regarding short-term risk, AIRS is more volatile compared to HCA. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs FMS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, FMS has a market cap of 16.88B. Regarding current trading prices, AIRS is priced at $3.57, while FMS trades at $28.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas FMS's P/E ratio is 24.38. In terms of profitability, AIRS's ROE is -0.21%, compared to FMS's ROE of +0.04%. Regarding short-term risk, AIRS is more volatile compared to FMS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs THC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, THC has a market cap of 15.36B. Regarding current trading prices, AIRS is priced at $3.57, while THC trades at $165.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas THC's P/E ratio is 10.61. In terms of profitability, AIRS's ROE is -0.21%, compared to THC's ROE of +0.37%. Regarding short-term risk, AIRS is more volatile compared to THC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs SOLV Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, SOLV has a market cap of 12.82B. Regarding current trading prices, AIRS is priced at $3.57, while SOLV trades at $74.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas SOLV's P/E ratio is 34.15. In terms of profitability, AIRS's ROE is -0.21%, compared to SOLV's ROE of +0.12%. Regarding short-term risk, AIRS is more volatile compared to SOLV. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs UHS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, UHS has a market cap of 12.76B. Regarding current trading prices, AIRS is priced at $3.57, while UHS trades at $198.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas UHS's P/E ratio is 11.12. In terms of profitability, AIRS's ROE is -0.21%, compared to UHS's ROE of +0.18%. Regarding short-term risk, AIRS is more volatile compared to UHS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs EHC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, EHC has a market cap of 12.18B. Regarding current trading prices, AIRS is priced at $3.57, while EHC trades at $120.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas EHC's P/E ratio is 24.91. In terms of profitability, AIRS's ROE is -0.21%, compared to EHC's ROE of +0.25%. Regarding short-term risk, AIRS is more volatile compared to EHC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs DVA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, DVA has a market cap of 10.98B. Regarding current trading prices, AIRS is priced at $3.57, while DVA trades at $145.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas DVA's P/E ratio is 14.41. In terms of profitability, AIRS's ROE is -0.21%, compared to DVA's ROE of +3.94%. Regarding short-term risk, AIRS is more volatile compared to DVA. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs OSH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, OSH has a market cap of 9.52B. Regarding current trading prices, AIRS is priced at $3.57, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas OSH's P/E ratio is -17.65. In terms of profitability, AIRS's ROE is -0.21%, compared to OSH's ROE of +4.64%. Regarding short-term risk, AIRS is more volatile compared to OSH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs ENSG Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ENSG has a market cap of 8.61B. Regarding current trading prices, AIRS is priced at $3.57, while ENSG trades at $149.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ENSG's P/E ratio is 28.25. In terms of profitability, AIRS's ROE is -0.21%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, AIRS is more volatile compared to ENSG. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs CHE Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CHE has a market cap of 8.48B. Regarding current trading prices, AIRS is priced at $3.57, while CHE trades at $579.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CHE's P/E ratio is 28.22. In terms of profitability, AIRS's ROE is -0.21%, compared to CHE's ROE of +0.26%. Regarding short-term risk, AIRS is more volatile compared to CHE. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs OPCH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, OPCH has a market cap of 5.44B. Regarding current trading prices, AIRS is priced at $3.57, while OPCH trades at $33.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas OPCH's P/E ratio is 26.58. In terms of profitability, AIRS's ROE is -0.21%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, AIRS is more volatile compared to OPCH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs LHCG Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, LHCG has a market cap of 5.29B. Regarding current trading prices, AIRS is priced at $3.57, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas LHCG's P/E ratio is 82.83. In terms of profitability, AIRS's ROE is -0.21%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, AIRS is more volatile compared to LHCG. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AMED Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AMED has a market cap of 3.11B. Regarding current trading prices, AIRS is priced at $3.57, while AMED trades at $94.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AMED's P/E ratio is 34.92. In terms of profitability, AIRS's ROE is -0.21%, compared to AMED's ROE of +0.10%. Regarding short-term risk, AIRS is more volatile compared to AMED. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs SGRY Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, SGRY has a market cap of 3.07B. Regarding current trading prices, AIRS is priced at $3.57, while SGRY trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas SGRY's P/E ratio is -15.65. In terms of profitability, AIRS's ROE is -0.21%, compared to SGRY's ROE of -0.10%. Regarding short-term risk, AIRS is more volatile compared to SGRY. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs ACHC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ACHC has a market cap of 2.41B. Regarding current trading prices, AIRS is priced at $3.57, while ACHC trades at $26.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ACHC's P/E ratio is 9.41. In terms of profitability, AIRS's ROE is -0.21%, compared to ACHC's ROE of +0.06%. Regarding short-term risk, AIRS is more volatile compared to ACHC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs LFST Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, LFST has a market cap of 2.27B. Regarding current trading prices, AIRS is priced at $3.57, while LFST trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas LFST's P/E ratio is -64.89. In terms of profitability, AIRS's ROE is -0.21%, compared to LFST's ROE of -0.02%. Regarding short-term risk, AIRS is more volatile compared to LFST. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs ARDT Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ARDT has a market cap of 2.21B. Regarding current trading prices, AIRS is priced at $3.57, while ARDT trades at $15.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ARDT's P/E ratio is 9.76. In terms of profitability, AIRS's ROE is -0.21%, compared to ARDT's ROE of +0.24%. Regarding short-term risk, AIRS is more volatile compared to ARDT. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs ADUS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ADUS has a market cap of 2.05B. Regarding current trading prices, AIRS is priced at $3.57, while ADUS trades at $111.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ADUS's P/E ratio is 25.26. In terms of profitability, AIRS's ROE is -0.21%, compared to ADUS's ROE of +0.08%. Regarding short-term risk, AIRS is more volatile compared to ADUS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs SEM Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, SEM has a market cap of 1.97B. Regarding current trading prices, AIRS is priced at $3.57, while SEM trades at $15.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas SEM's P/E ratio is 24.77. In terms of profitability, AIRS's ROE is -0.21%, compared to SEM's ROE of +0.10%. Regarding short-term risk, AIRS is more volatile compared to SEM. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AMEH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AMEH has a market cap of 1.83B. Regarding current trading prices, AIRS is priced at $3.57, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AMEH's P/E ratio is 39.25. In terms of profitability, AIRS's ROE is -0.21%, compared to AMEH's ROE of +0.07%. Regarding short-term risk, AIRS is more volatile compared to AMEH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs NHC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, NHC has a market cap of 1.68B. Regarding current trading prices, AIRS is priced at $3.57, while NHC trades at $108.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas NHC's P/E ratio is 15.73. In terms of profitability, AIRS's ROE is -0.21%, compared to NHC's ROE of +0.11%. Regarding short-term risk, AIRS is more volatile compared to NHC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs BKD Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, BKD has a market cap of 1.62B. Regarding current trading prices, AIRS is priced at $3.57, while BKD trades at $6.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas BKD's P/E ratio is -6.63. In terms of profitability, AIRS's ROE is -0.21%, compared to BKD's ROE of -0.96%. Regarding short-term risk, AIRS is more volatile compared to BKD. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs ASTH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ASTH has a market cap of 1.36B. Regarding current trading prices, AIRS is priced at $3.57, while ASTH trades at $27.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ASTH's P/E ratio is 37.23. In terms of profitability, AIRS's ROE is -0.21%, compared to ASTH's ROE of +0.07%. Regarding short-term risk, AIRS is more volatile compared to ASTH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs MD Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, MD has a market cap of 1.28B. Regarding current trading prices, AIRS is priced at $3.57, while MD trades at $14.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas MD's P/E ratio is -14.92. In terms of profitability, AIRS's ROE is -0.21%, compared to MD's ROE of -0.11%. Regarding short-term risk, AIRS is more volatile compared to MD. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs BKDT Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, BKDT has a market cap of 1.23B. Regarding current trading prices, AIRS is priced at $3.57, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas BKDT's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to BKDT's ROE of -0.96%. Regarding short-term risk, AIRS is more volatile compared to BKDT. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs USPH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, USPH has a market cap of 1.21B. Regarding current trading prices, AIRS is priced at $3.57, while USPH trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas USPH's P/E ratio is 43.46. In terms of profitability, AIRS's ROE is -0.21%, compared to USPH's ROE of +0.06%. Regarding short-term risk, AIRS is more volatile compared to USPH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AVAH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AVAH has a market cap of 1.17B. Regarding current trading prices, AIRS is priced at $3.57, while AVAH trades at $5.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AVAH's P/E ratio is -99.83. In terms of profitability, AIRS's ROE is -0.21%, compared to AVAH's ROE of -0.12%. Regarding short-term risk, AIRS is more volatile compared to AVAH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs HCSG Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, HCSG has a market cap of 1.08B. Regarding current trading prices, AIRS is priced at $3.57, while HCSG trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas HCSG's P/E ratio is 26.91. In terms of profitability, AIRS's ROE is -0.21%, compared to HCSG's ROE of +0.08%. Regarding short-term risk, AIRS is more volatile compared to HCSG. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs PNTG Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, PNTG has a market cap of 1.04B. Regarding current trading prices, AIRS is priced at $3.57, while PNTG trades at $30.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas PNTG's P/E ratio is 39.76. In terms of profitability, AIRS's ROE is -0.21%, compared to PNTG's ROE of +0.11%. Regarding short-term risk, AIRS is more volatile compared to PNTG. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AGL Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AGL has a market cap of 1.02B. Regarding current trading prices, AIRS is priced at $3.57, while AGL trades at $2.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AGL's P/E ratio is -3.96. In terms of profitability, AIRS's ROE is -0.21%, compared to AGL's ROE of -0.44%. Regarding short-term risk, AIRS is more volatile compared to AGL. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AMN Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AMN has a market cap of 869.06M. Regarding current trading prices, AIRS is priced at $3.57, while AMN trades at $22.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AMN's P/E ratio is -5.24. In terms of profitability, AIRS's ROE is -0.21%, compared to AMN's ROE of -0.21%. Regarding short-term risk, AIRS is more volatile compared to AMN. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs CYH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CYH has a market cap of 611.03M. Regarding current trading prices, AIRS is priced at $3.57, while CYH trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CYH's P/E ratio is -1.18. In terms of profitability, AIRS's ROE is -0.21%, compared to CYH's ROE of +0.30%. Regarding short-term risk, AIRS is more volatile compared to CYH. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs INNV Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, INNV has a market cap of 565.70M. Regarding current trading prices, AIRS is priced at $3.57, while INNV trades at $4.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas INNV's P/E ratio is -17.46. In terms of profitability, AIRS's ROE is -0.21%, compared to INNV's ROE of -0.12%. Regarding short-term risk, AIRS is more volatile compared to INNV. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs EHAB Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, EHAB has a market cap of 540.05M. Regarding current trading prices, AIRS is priced at $3.57, while EHAB trades at $10.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas EHAB's P/E ratio is -3.85. In terms of profitability, AIRS's ROE is -0.21%, compared to EHAB's ROE of -0.31%. Regarding short-term risk, AIRS is more volatile compared to EHAB. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AUNA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AUNA has a market cap of 514.39M. Regarding current trading prices, AIRS is priced at $3.57, while AUNA trades at $6.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AUNA's P/E ratio is 15.80. In terms of profitability, AIRS's ROE is -0.21%, compared to AUNA's ROE of +0.07%. Regarding short-term risk, AIRS is more volatile compared to AUNA. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs TALK Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, TALK has a market cap of 498.60M. Regarding current trading prices, AIRS is priced at $3.57, while TALK trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas TALK's P/E ratio is 149.00. In terms of profitability, AIRS's ROE is -0.21%, compared to TALK's ROE of -0.04%. Regarding short-term risk, AIRS is more volatile compared to TALK. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs SNDA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, SNDA has a market cap of 494.65M. Regarding current trading prices, AIRS is priced at $3.57, while SNDA trades at $26.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas SNDA's P/E ratio is -48.56. In terms of profitability, AIRS's ROE is -0.21%, compared to SNDA's ROE of -0.53%. Regarding short-term risk, AIRS is more volatile compared to SNDA. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs CCRN Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CCRN has a market cap of 458.64M. Regarding current trading prices, AIRS is priced at $3.57, while CCRN trades at $13.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CCRN's P/E ratio is -25.91. In terms of profitability, AIRS's ROE is -0.21%, compared to CCRN's ROE of -0.04%. Regarding short-term risk, AIRS is more volatile compared to CCRN. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs TALKW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, TALKW has a market cap of 433.20M. Regarding current trading prices, AIRS is priced at $3.57, while TALKW trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas TALKW's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to TALKW's ROE of -0.04%. Regarding short-term risk, AIRS is less volatile compared to TALKW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs CMPS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CMPS has a market cap of 369.54M. Regarding current trading prices, AIRS is priced at $3.57, while CMPS trades at $3.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CMPS's P/E ratio is -2.00. In terms of profitability, AIRS's ROE is -0.21%, compared to CMPS's ROE of -0.72%. Regarding short-term risk, AIRS is more volatile compared to CMPS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs TOI Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, TOI has a market cap of 266.69M. Regarding current trading prices, AIRS is priced at $3.57, while TOI trades at $2.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas TOI's P/E ratio is -4.21. In terms of profitability, AIRS's ROE is -0.21%, compared to TOI's ROE of -5.10%. Regarding short-term risk, AIRS is less volatile compared to TOI. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs CSU Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CSU has a market cap of 223.71M. Regarding current trading prices, AIRS is priced at $3.57, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CSU's P/E ratio is 0.67. In terms of profitability, AIRS's ROE is -0.21%, compared to CSU's ROE of +2.23%. Regarding short-term risk, AIRS is more volatile compared to CSU. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs TOIIW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, TOIIW has a market cap of 212.37M. Regarding current trading prices, AIRS is priced at $3.57, while TOIIW trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas TOIIW's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to TOIIW's ROE of -5.10%. Regarding short-term risk, AIRS is less volatile compared to TOIIW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs AONC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AONC has a market cap of 204.45M. Regarding current trading prices, AIRS is priced at $3.57, while AONC trades at $6.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AONC's P/E ratio is -7.85. In terms of profitability, AIRS's ROE is -0.21%, compared to AONC's ROE of +0.25%. Regarding short-term risk, AIRS is more volatile compared to AONC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs BTMD Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, BTMD has a market cap of 157.01M. Regarding current trading prices, AIRS is priced at $3.57, while BTMD trades at $4.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas BTMD's P/E ratio is 7.07. In terms of profitability, AIRS's ROE is -0.21%, compared to BTMD's ROE of -0.19%. Regarding short-term risk, AIRS is more volatile compared to BTMD. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs JYNT Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, JYNT has a market cap of 154.71M. Regarding current trading prices, AIRS is priced at $3.57, while JYNT trades at $10.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas JYNT's P/E ratio is -101.10. In terms of profitability, AIRS's ROE is -0.21%, compared to JYNT's ROE of -0.43%. Regarding short-term risk, AIRS is more volatile compared to JYNT. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs DCGO Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, DCGO has a market cap of 145.68M. Regarding current trading prices, AIRS is priced at $3.57, while DCGO trades at $1.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas DCGO's P/E ratio is -147.00. In terms of profitability, AIRS's ROE is -0.21%, compared to DCGO's ROE of -0.00%. Regarding short-term risk, AIRS is less volatile compared to DCGO. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs FVE Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, FVE has a market cap of 98.39M. Regarding current trading prices, AIRS is priced at $3.57, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas FVE's P/E ratio is -5.64. In terms of profitability, AIRS's ROE is -0.21%, compared to FVE's ROE of -0.15%. Regarding short-term risk, AIRS is more volatile compared to FVE. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs PIII Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, PIII has a market cap of 57.39M. Regarding current trading prices, AIRS is priced at $3.57, while PIII trades at $7.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas PIII's P/E ratio is -0.15. In terms of profitability, AIRS's ROE is -0.21%, compared to PIII's ROE of -1.49%. Regarding short-term risk, AIRS is more volatile compared to PIII. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs PIIIW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, PIIIW has a market cap of 47.90M. Regarding current trading prices, AIRS is priced at $3.57, while PIIIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas PIIIW's P/E ratio is -0.01. In terms of profitability, AIRS's ROE is -0.21%, compared to PIIIW's ROE of -1.49%. Regarding short-term risk, AIRS is less volatile compared to PIIIW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs KDLYW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, KDLYW has a market cap of 47.12M. Regarding current trading prices, AIRS is priced at $3.57, while KDLYW trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas KDLYW's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to KDLYW's ROE of -1.46%. Regarding short-term risk, AIRS is less volatile compared to KDLYW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs ALR Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ALR has a market cap of 44.18M. Regarding current trading prices, AIRS is priced at $3.57, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ALR's P/E ratio is -1.11. In terms of profitability, AIRS's ROE is -0.21%, compared to ALR's ROE of -0.15%. Regarding short-term risk, AIRS is more volatile compared to ALR. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs CCEL Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CCEL has a market cap of 40.17M. Regarding current trading prices, AIRS is priced at $3.57, while CCEL trades at $4.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CCEL's P/E ratio is 497.00. In terms of profitability, AIRS's ROE is -0.21%, compared to CCEL's ROE of -0.01%. Regarding short-term risk, AIRS is more volatile compared to CCEL. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs IMAC Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, IMAC has a market cap of 33.08M. Regarding current trading prices, AIRS is priced at $3.57, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas IMAC's P/E ratio is -2.27. In terms of profitability, AIRS's ROE is -0.21%, compared to IMAC's ROE of +2.46%. Regarding short-term risk, AIRS is more volatile compared to IMAC. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AMS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AMS has a market cap of 16.74M. Regarding current trading prices, AIRS is priced at $3.57, while AMS trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AMS's P/E ratio is 7.86. In terms of profitability, AIRS's ROE is -0.21%, compared to AMS's ROE of +0.06%. Regarding short-term risk, AIRS is more volatile compared to AMS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs AIH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, AIH has a market cap of 15.93M. Regarding current trading prices, AIRS is priced at $3.57, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas AIH's P/E ratio is -2.78. In terms of profitability, AIRS's ROE is -0.21%, compared to AIH's ROE of -0.79%. Regarding short-term risk, AIRS is less volatile compared to AIH. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs MODV Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, MODV has a market cap of 13.27M. Regarding current trading prices, AIRS is priced at $3.57, while MODV trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas MODV's P/E ratio is -0.06. In terms of profitability, AIRS's ROE is -0.21%, compared to MODV's ROE of +6.87%. Regarding short-term risk, AIRS is less volatile compared to MODV. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs CANO Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CANO has a market cap of 12.43M. Regarding current trading prices, AIRS is priced at $3.57, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CANO's P/E ratio is -0.01. In terms of profitability, AIRS's ROE is -0.21%, compared to CANO's ROE of -1.49%. Regarding short-term risk, AIRS is less volatile compared to CANO. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs FTRP Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, FTRP has a market cap of 9.81M. Regarding current trading prices, AIRS is priced at $3.57, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas FTRP's P/E ratio is -1.22. In terms of profitability, AIRS's ROE is -0.21%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, AIRS is more volatile compared to FTRP. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs MNDR Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, MNDR has a market cap of 5.79M. Regarding current trading prices, AIRS is priced at $3.57, while MNDR trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas MNDR's P/E ratio is -0.30. In terms of profitability, AIRS's ROE is -0.21%, compared to MNDR's ROE of -5.70%. Regarding short-term risk, AIRS is more volatile compared to MNDR. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs GBNH Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, GBNH has a market cap of 5.52M. Regarding current trading prices, AIRS is priced at $3.57, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas GBNH's P/E ratio is -0.06. In terms of profitability, AIRS's ROE is -0.21%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, AIRS is less volatile compared to GBNH. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs RHE Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, RHE has a market cap of 5.21M. Regarding current trading prices, AIRS is priced at $3.57, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas RHE's P/E ratio is -1.79. In terms of profitability, AIRS's ROE is -0.21%, compared to RHE's ROE of +1.52%. Regarding short-term risk, AIRS is less volatile compared to RHE. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs ATIP Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, ATIP has a market cap of 3.97M. Regarding current trading prices, AIRS is priced at $3.57, while ATIP trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas ATIP's P/E ratio is -0.05. In terms of profitability, AIRS's ROE is -0.21%, compared to ATIP's ROE of +1.77%. Regarding short-term risk, AIRS is less volatile compared to ATIP. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs IMACW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, IMACW has a market cap of 1.74M. Regarding current trading prices, AIRS is priced at $3.57, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas IMACW's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to IMACW's ROE of +2.46%. Regarding short-term risk, AIRS is less volatile compared to IMACW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs CCM Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, CCM has a market cap of 1.22M. Regarding current trading prices, AIRS is priced at $3.57, while CCM trades at $8.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas CCM's P/E ratio is -0.86. In terms of profitability, AIRS's ROE is -0.21%, compared to CCM's ROE of +0.13%. Regarding short-term risk, AIRS is less volatile compared to CCM. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs SYRA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, SYRA has a market cap of 1.01M. Regarding current trading prices, AIRS is priced at $3.57, while SYRA trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas SYRA's P/E ratio is -0.27. In terms of profitability, AIRS's ROE is -0.21%, compared to SYRA's ROE of -1.04%. Regarding short-term risk, AIRS is more volatile compared to SYRA. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs RHE-PA Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, RHE-PA has a market cap of 674535.00. Regarding current trading prices, AIRS is priced at $3.57, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, AIRS's ROE is -0.21%, compared to RHE-PA's ROE of +1.52%. Regarding short-term risk, AIRS is less volatile compared to RHE-PA. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs NVOS Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, NVOS has a market cap of 582041.00. Regarding current trading prices, AIRS is priced at $3.57, while NVOS trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas NVOS's P/E ratio is -0.02. In terms of profitability, AIRS's ROE is -0.21%, compared to NVOS's ROE of -1.20%. Regarding short-term risk, AIRS is more volatile compared to NVOS. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs BACK Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, BACK has a market cap of 119605.00. Regarding current trading prices, AIRS is priced at $3.57, while BACK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas BACK's P/E ratio is -0.01. In terms of profitability, AIRS's ROE is -0.21%, compared to BACK's ROE of +2.46%. Regarding short-term risk, AIRS is more volatile compared to BACK. This indicates potentially higher risk in terms of short-term price fluctuations for AIRS.
AIRS vs NIVFW Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, NIVFW has a market cap of 8299.00. Regarding current trading prices, AIRS is priced at $3.57, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas NIVFW's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to NIVFW's ROE of -0.39%. Regarding short-term risk, AIRS is less volatile compared to NIVFW. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.
AIRS vs IONM Comparison
AIRS plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AIRS stands at 209.84M. In comparison, IONM has a market cap of 313.00. Regarding current trading prices, AIRS is priced at $3.57, while IONM trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AIRS currently has a P/E ratio of -12.31, whereas IONM's P/E ratio is N/A. In terms of profitability, AIRS's ROE is -0.21%, compared to IONM's ROE of +0.75%. Regarding short-term risk, AIRS is less volatile compared to IONM. This indicates potentially lower risk in terms of short-term price fluctuations for AIRS.